Studies related to Binge-eating and Chromium

A Double-blind, Randomized Pilot Trial Of Chromium Picolinate For Binge Eating Disorder: Results Of The Binge Eating And Chromium (BEACh) Study

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 24
Gender Both Genders
Age Range 18-29, 30-44
Body Types Obese
Notes for this study:
Six months supplementation of chromium as picolinate (600µg or 1000µg) was able to nonsignificantly reduce symptoms of binge eating disorder (binge frequency) and weight relative to placebo, while HbA1c and blood glucose also failed to reach statistically significant reductions despite trends to do so.

Full details on all 1 studies are available to Examine Plus members.

Already a member? Login now to access.